MedPath

A Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Gallbladder Stone
Gallbladder Polyp
Interventions
Procedure: laparoscopic cholecystectomy
Registration Number
NCT02185586
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

We have designed a new method which could be used in laparoscopic cholecy- stectomy.Account to this new method, the three incisions are all located on the lower abdominal, theoretically it could get more beautiful outlook and less stress response than traditional laparoscopic cholecystectomy(two of the three incisions located on upper abdomen) or single port laparoscopic cholecystectomy(one large incision located on umbilicus).

We plan to conduct a randomized controlled trial to compare those there methods of laparoscopic cholecystectomy, in order to find out if there will be some advantages of this new method,such as in lowering the stress response,reducing impact on respiration, relieving post-operation pain and improving appearance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • age from 18 to 70 years old
  • benign diseases of gallbladder
  • selective cholecystectomy
  • Capable to read and write
Exclusion Criteria
  • accept upper abdominal operation before
  • acute cholecystitis
  • with serious heart or pulmonary diseases
  • with diseases of immune system
  • Pregnant women
  • can not understand the research purposes
  • relatives of researchers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SLClaparoscopic cholecystectomysingle laparoscopic cholecystectomy
UALClaparoscopic cholecystectomyupper abdominal laparoscopic cholecystectomy
LALClaparoscopic cholecystectomylower abdominal laparoscopic cholecystectomy
Primary Outcome Measures
NameTimeMethod
Systematic inflammatory response caused by the surgical traumaone day before the operation,8 hours after the operation,one day after the operation

Blood IL-6,TNF-α,and CRP levels determined by ELISA at different time-points,

Secondary Outcome Measures
NameTimeMethod
36-item health survey3 months after the operation
pulmonary functionone day before the operation, one day after the operation
Cosmesis and body image score1 and 3 months after the operation
Post-operation pain score (visual analog scale, VAS)12 and 24 hours after the operation

Trial Locations

Locations (1)

Department of hepatobiliary surgery,China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath